Antibiotic Therapy for Crohn’s Disease: A Review

Increasing evidence suggests that gut bacteria play a pathogenic role in Crohn’s disease (CD), providing a rationale for the use of antibiotics in the primary treatment of the disease. While there are data to suggest that antibiotics may be effective in treating active luminal, particularly colonic,...

Full description

Saved in:
Bibliographic Details
Main Authors: Simon Lal, A Hillary Steinhart
Format: Article
Language:English
Published: Wiley 2006-01-01
Series:Canadian Journal of Gastroenterology
Online Access:http://dx.doi.org/10.1155/2006/250490
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832562855719731200
author Simon Lal
A Hillary Steinhart
author_facet Simon Lal
A Hillary Steinhart
author_sort Simon Lal
collection DOAJ
description Increasing evidence suggests that gut bacteria play a pathogenic role in Crohn’s disease (CD), providing a rationale for the use of antibiotics in the primary treatment of the disease. While there are data to suggest that antibiotics may be effective in treating active luminal, particularly colonic, and/or perianal CD, evidence for their use in these settings is hampered by the lack of well-designed, adequately powered, placebo-controlled trials. Furthermore, although nitroimidazole antibiotics have been shown to reduce postoperative recurrence following ileocolonic resection, their use is limited by side effects. There is a current need for rigorous multicentre studies looking into the role of antibiotics in treating perianal and luminal CD, as well as a need for the large-scale assessment of novel antibiotics, with low systemic absorption, which may improve patient tolerance.
format Article
id doaj-art-10815d9321744538a707cf819d29e3bc
institution Kabale University
issn 0835-7900
language English
publishDate 2006-01-01
publisher Wiley
record_format Article
series Canadian Journal of Gastroenterology
spelling doaj-art-10815d9321744538a707cf819d29e3bc2025-02-03T01:21:31ZengWileyCanadian Journal of Gastroenterology0835-79002006-01-01201065165510.1155/2006/250490Antibiotic Therapy for Crohn’s Disease: A ReviewSimon Lal0A Hillary Steinhart1Inflammatory Bowel Disease Centre, Mount Sinai Hospital, Toronto, Ontario, CanadaInflammatory Bowel Disease Centre, Mount Sinai Hospital, Toronto, Ontario, CanadaIncreasing evidence suggests that gut bacteria play a pathogenic role in Crohn’s disease (CD), providing a rationale for the use of antibiotics in the primary treatment of the disease. While there are data to suggest that antibiotics may be effective in treating active luminal, particularly colonic, and/or perianal CD, evidence for their use in these settings is hampered by the lack of well-designed, adequately powered, placebo-controlled trials. Furthermore, although nitroimidazole antibiotics have been shown to reduce postoperative recurrence following ileocolonic resection, their use is limited by side effects. There is a current need for rigorous multicentre studies looking into the role of antibiotics in treating perianal and luminal CD, as well as a need for the large-scale assessment of novel antibiotics, with low systemic absorption, which may improve patient tolerance.http://dx.doi.org/10.1155/2006/250490
spellingShingle Simon Lal
A Hillary Steinhart
Antibiotic Therapy for Crohn’s Disease: A Review
Canadian Journal of Gastroenterology
title Antibiotic Therapy for Crohn’s Disease: A Review
title_full Antibiotic Therapy for Crohn’s Disease: A Review
title_fullStr Antibiotic Therapy for Crohn’s Disease: A Review
title_full_unstemmed Antibiotic Therapy for Crohn’s Disease: A Review
title_short Antibiotic Therapy for Crohn’s Disease: A Review
title_sort antibiotic therapy for crohn s disease a review
url http://dx.doi.org/10.1155/2006/250490
work_keys_str_mv AT simonlal antibiotictherapyforcrohnsdiseaseareview
AT ahillarysteinhart antibiotictherapyforcrohnsdiseaseareview